検索
Q32 Bio Inc
QTTBウォッチリストに追加
9.220USD
-0.340-3.56%
終値 09-24 16:00（ET）
274.39M時価総額
3.30直近12ヶ月PER
Q32 Bio Incについて 企業名
Q32 Bio Inc. is a clinical-stage biotechnology company whose science targets potent regulators of the adaptive immune system to re-balance immunity in autoimmune and inflammatory diseases. It focuses on developing novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. Bempikibart (ADX-914), its advanced product candidate, is a fully human anti-interleukin-7 receptor alpha (IL-7Rα), an antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 (IL-7), and thymic stromal lymphopoietin (TSLP). It has completed two Phase IIa clinical trials evaluating bempikibart, SIGNAL-AA for the treatment of alopecia areata (AA), and SIGNAL-AD for the treatment of atopic dermatitis (AD). ADX-097, a Phase 2 asset and the lead product candidate from its complement inhibitor platform, is a humanized anti-C3d monoclonal antibody, fusion protein.
Q32 Bio Inc プロフィール
企業コードQTTB
会社名Q32 Bio Inc
上場日Mar 28, 2018
最高経営責任者「CEO」Morrison (Jodie Pope)
従業員数42
証券種類Ordinary Share
決算期末Mar 28
本社所在地830 Winter Street
都市WALTHAM
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号02451
電話番号17819990232
ウェブサイトhttps://www.q32bio.com/
企業コードQTTB
上場日Mar 28, 2018
最高経営責任者「CEO」Morrison (Jodie Pope)
Q32 Bio Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Jodie Pope Morrison
Ms. Jodie Pope Morrison
Chief Executive Officer, Director
Chief Executive Officer, Director
145.26K
-6.78%
Ms. Jodie Pope Morrison
Ms. Jodie Pope Morrison
Chief Executive Officer, Director
Chief Executive Officer, Director
145.26K
-6.78%
Ms. Jodie Pope Morrison
Ms. Jodie Pope Morrison
Chief Executive Officer, Director
Chief Executive Officer, Director
145.26K
-6.78%
Dr. Shelia M. Violette, Ph.D.
Dr. Shelia M. Violette, Ph.D.
Chief Scientific Officer, President of Research
Chief Scientific Officer, President of Research
107.80K
-2.60%
Dr. Shelia M. Violette, Ph.D.
Dr. Shelia M. Violette, Ph.D.
Chief Scientific Officer, President of Research
Chief Scientific Officer, President of Research
107.80K
-2.60%
Dr. Shelia M. Violette, Ph.D.
Dr. Shelia M. Violette, Ph.D.
Chief Scientific Officer, President of Research
Chief Scientific Officer, President of Research
107.80K
-2.60%
Dr. Isaac Manke, Ph.D.
Dr. Isaac Manke, Ph.D.
Independent Director
Independent Director
53.52K
--
Dr. Isaac Manke, Ph.D.
Dr. Isaac Manke, Ph.D.
Independent Director
Independent Director
53.52K
--
Dr. Isaac Manke, Ph.D.
Dr. Isaac Manke, Ph.D.
Independent Director
Independent Director
53.52K
--
Dr. Arthur O. Tzianabos, Ph.D.
Dr. Arthur O. Tzianabos, Ph.D.
Director
Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Jodie Pope Morrison
Ms. Jodie Pope Morrison
Chief Executive Officer, Director
Chief Executive Officer, Director
145.26K
-6.78%
Ms. Jodie Pope Morrison
Ms. Jodie Pope Morrison
Chief Executive Officer, Director
Chief Executive Officer, Director
145.26K
-6.78%
Ms. Jodie Pope Morrison
Ms. Jodie Pope Morrison
Chief Executive Officer, Director
Chief Executive Officer, Director
145.26K
-6.78%
Dr. Shelia M. Violette, Ph.D.
Dr. Shelia M. Violette, Ph.D.
Chief Scientific Officer, President of Research
Chief Scientific Officer, President of Research
107.80K
-2.60%
Dr. Shelia M. Violette, Ph.D.
Dr. Shelia M. Violette, Ph.D.
Chief Scientific Officer, President of Research
Chief Scientific Officer, President of Research
107.80K
-2.60%
Dr. Shelia M. Violette, Ph.D.
Dr. Shelia M. Violette, Ph.D.
Chief Scientific Officer, President of Research
Chief Scientific Officer, President of Research
107.80K
-2.60%
よくある質問
Q32 Bio Incの上位5名の株主は誰ですか？
Q32 Bio Incの上位5名の株主は以下のとおりです。Ms. Jodie Pope Morrison
Q32 Bio Inc（QTTB）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Q32 Bio Incの株式を保有している機関は189社あり、保有株式の総市場価値は約9.99Mで、全体の65.09%を占めています。2025Q4と比較して、機関の持ち株は-2048479.00増加しています。